1) uracil
[英]['jurəsil] [美]['jʊrəsəl]
脲嘧啶
1.
Research progress on herbicidally active uracil derivatives;
具除草活性的脲嘧啶类化合物的研究进展
2.
Synthesis and Molecular Structure of 1-(3,4-Dimethoxy)- phenethyl-3-epoxypropyl-5-cyano-6-methyluracil;
1-(3,4-二甲氧基)苯乙基-3-环氧丙基-5-氰基-6-甲基脲嘧啶的合成及晶体结构
3.
Studies on Synthesis and Bioactivity of Novel Uracil Compounds;
脲嘧啶类化合物的合成及其生物活性研究
2) fluorouracil
[英][,flu:ərəu'jurəsil] [美][,flʊro'jʊrəsɪl, ,flɔr-, ,flor-]
氟脲嘧啶
1.
Bovin serum albumin microspheres containing 5-fluorouracil(FU-BM) were prepared by emulsion-direct heat stabilization technique.
目的:探讨以牛血清白蛋白为载体的氟脲嘧啶白蛋白微球的最佳制备方法及有关体外性质。
2.
Objective To explore the efficacy and safety of FOLFOX4 regimen including oxaliplatin(L-OHP),fluorouracil(5-Fu) and calcium folinate(CF) as therapy for patients with advanced gastric cancer.
目的观察奥沙利铂(L-OHP)联合氟脲嘧啶(5-Fu)、亚叶酸钙(CF)组成的FOLFOX4方案治疗晚期胃癌的近期疗效和毒副反应。
3.
Objective To study the effect and toxicity of the regimen of Oxaliplatin combined with Fluorouracil and Leucovorin in the treatment of advanced colorectal Cancer.
目的观察奥沙利铂(L-OHP)联合氟脲嘧啶(5-Fu)及亚叶酸钙(CF)治疗晚期大肠癌的疗效和不良反应。
3) 5-Fluorouracil
氟脲嘧啶
1.
Oxaliplatin Combined with 5-Fluorouracil for Advanced Gastric Carcinoma:a Report of 42 Cases;
奥沙利铂联合氟脲嘧啶治疗晚期胃癌42例临床观察
2.
Clinical Observation of Late Stage Gastrointestinal Tumor Patients Treated Principally by Compound Injection of Polyphase Liposome of 5-Fluorouracil;
复方氟脲嘧啶脂质体治疗晚期消化系统肿瘤的疗效观察
3.
Objective To evaluate the efficacy and toxicity of weekly paclitaxel(PTX) combined with 5-fluorouracil(5-Fu),DDP and CF as alternative chemotherapy for patients with advanced esophageal carcinoma.
目的评价周剂量紫杉醇(PTX)联合氟脲嘧啶(5-Fu)、顺铂(DDP)和醛氢叶酸(CF)组成PLFP方案治疗晚期食管癌的临床疗效和毒副反应。
4) 5-Fu
氟脲嘧啶
1.
Clinical observation of oxaliplatin combined with leucovorin and 5-Fu in advanced gastric carcinoma;
草酸铂联合亚叶酸钙氟脲嘧啶治疗晚期胃癌的临床观察
2.
Tissue Penetration of Capecitabine and Its Tumor-Selective Delivery of 5-FU in Advanced Breast Cancer Patients;
卡培他滨乳腺组织穿透及向氟脲嘧啶转化的药动学研究(英文)
3.
Pharmacokinetic analysis on the tissue penetration of capecitabine and tumor selective distribution of 5-FU in patients with advanced breast cancer;
卡培他滨乳腺组织穿透及向氟脲嘧啶转化的药动学研究
5) Pyrimidylurea
嘧啶脲
补充资料：脲嘧啶
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条